摘要
目的:探讨阿奇霉素序贯疗法在临床小儿肺炎支原体肺炎(MPP)治疗中的应用与效果.方法:回顾性分析我院收治的78例MMP患儿临床资料,采取数字随机法将其分成甲乙两组各39例,分别给予其红霉素序贯疗法和阿奇霉素序贯疗法治疗,对比分析两组患儿治疗效果、各项临床症状与炎性反应缓解情况与不良反应发生情况.结果:甲组治疗总有效率为82.05％,显著低于乙组的94.87％(P＜0.05),且甲乙组不良反应总发生率分别为7.69％、2.56％,乙组低于甲组,但两组组间差异无统计学意义(P＞0.05);同时,甲组临床各项症
Abstract
Objective To investigate the application and effect of azithromycin sequential therapy in the treatment of mycoplasma pneumonia (MPP) in children.Methods Clinical data of 78 children with MMP admitted to our hospital were retrospectively analyzed, and they were divided into two groups with 39 cases in each group by digital random method.They were respectively given erythromycin sequential therapy and azithromycin sequential therapy, and the therapeutic effect, clinical symptoms, remission of inflammatory response and occurrence of adverse reactions in the two groups were compared and analyzed.Results The total effective rate of group A was 82.05％, significantly lower than that of group B (94.87％) (P＜0.05), and the total incidence of adverse reactions in group A and B were 7.69％ and 2.56％, respectively, which were lower in group B than group A, but there was no statistical significance between the two groups (P＞0.05).At the same time, the disappearance time of clinical symptoms in group A was significantly later than that in group B, and the level of inflammatory factors in group A after treatment was significantly higher than that in group B,with statistical significance (P＜0.05).Conclusion According to the situation of clinical MPP children, azithromycin sequential therapy can significantly improve the clinical symptoms of children, reduce adverse reactions, improve the level of inflammatory factors, improve the therapeutic effect, worthy of clinical application.
万方数据